Chromatography Reagents Market Global Report 2026

The chromatography reagents market size has grown strongly in recent years. It will grow from $6.86 billion in 2025 to $7.46 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to growing expansion of pharmaceutical research and drug development activities, increasing adoption of chromatography techniques in clinical diagnostics, rising demand for accurate analytical testing in food and beverage industries, expansion of environmental monitoring and contaminant analysis applications, growing utilization of chromatography reagents in academic and research laboratories.

The chromatography reagents market size is expected to see strong growth in the next few years. It will grow to $10.49 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to increasing investment in biopharmaceutical and precision medicine research, rising demand for high sensitivity analytical testing solutions, growing adoption of advanced chromatography systems in forensic and clinical applications, expanding focus on quality assurance and regulatory compliance in analytical laboratories, increasing development of sustainable and high efficiency chromatography reagents. Major trends in the forecast period include increasing demand for ultra high purity chromatography reagents in analytical testing, rising adoption of advanced liquid chromatography techniques in pharmaceutical analysis, growing use of chromatography reagents in environmental and food safety testing, expanding application of high performance liquid chromatography grade solvents in research laboratories, increasing focus on reproducibility and accuracy in complex sample analysis.

The rising investment in drug discovery and development is expected to propel the growth of the chromatography reagents market going forward. Drug discovery and development refer to the process of identifying new drug candidates and advancing them through research, testing, and regulatory approval to become safe and effective medicines for patients. The increase in investment in drug discovery and development is driven by growing demand for innovative and targeted therapies, as it enables the faster development of effective treatments for complex and chronic diseases. Chromatography reagents support drug discovery and development by enabling the precise separation, identification, and purification of complex compounds, thereby supporting accurate drug candidate screening, purity assessment, and quality control throughout the research and development process. For instance, in July 2025, according to Department of Health and Social Care, a UK-based government public sector organization, expenditure on pharmaceutical research and development totaled $10.52 billion (£9 billion) in 2023, accounting for 17% of total business research and development expenditure in the same year. Therefore, the rising investment in drug discovery and development is driving the growth of the chromatography reagents market.

Leading companies operating in the chromatography reagents market are focusing on developing advanced solutions, such as high-quality microflow column technologies, to enhance analytical accuracy, reduce sample and solvent consumption, and improve detection performance in complex chemical and biological analyses. High-quality microflow column technologies refer to liquid chromatography column systems designed to operate at very low flow rates to enhance analytical sensitivity, reduce sample and solvent consumption, and improve detection efficiency. For example, in February 2026, Waters Corporation, a US-based analytical company, introduced next-generation microflow LC columns with MaxPeak Premier Technology. It is designed to support improved analytical sensitivity and efficiency. The solution enables higher-resolution separation, reduced sample and solvent usage, and enhanced reliability in complex biomolecular and pharmaceutical testing workflows.

In April 2026, Merck KGaA, a Germany-based science and technology company, acquired JSR Life Sciences' chromatography business for an undisclosed amount. Through this acquisition, Merck aims to strengthen its downstream bioprocessing portfolio by expanding its chromatography resin capabilities and enhancing its ability to support biologics manufacturing workflows. JSR Life Sciences is a US-based life sciences company specializing in providing high-performance chromatography resins, including Protein A affinity resins, used in the purification of monoclonal antibodies and other biologics.

Major companies operating in the chromatography reagents market are F Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Honeywell International Inc, Merck KGaA, GE HealthCare Technologies Inc, Tosoh Corporation, Agilent Technologies Inc, VWR International LLC, Illumina Inc, Daicel Corporation, Sartorius AG, Shimadzu Corporation, Waters Corporation, Revvity Inc, Bio-Rad Laboratories Inc, QIAGEN NV, Hamilton Company, Repligen Corporation, Promega Corporation, Porvair plc, GFS Chemicals Inc, Regis Technologies Inc, Tedia Company Inc, Santa Cruz Biotechnology Inc, Sterlitech Corporation.

North America was the largest region in the chromatography reagents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chromatography reagents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the chromatography reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chromatography reagents market consists of sales of hydrochloric acid, potassium hydroxide, tetrahydrofuran, and dichloromethane. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.